A retrospective study suggests that low dose Abilify is safe and may be helpful in reducing fatigue and post-exertional malaise and improving cognition and sleep in chronic fatigue syndrome. A placebo-controlled study is needed to determine how effective low dose Abilify is.
Jarred Younger – the creator of the Neuroinflammation, Pain and Fatigue Laboratory – is committed. He knows neuroinflammation plays a role in fibromyalgia (FM) and chronic fatigue syndrome (ME/CFS) and his lab is dedicated to showing that. So far –...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.